RxDoctor Payments Data

Victor Kim, MD

Pulmonary Disease · Philadelphia, PANPI 1467440412

Payments from drug & device makers

$33,052in general payments, 2019–2025

Across 13 payments — averaging $2542.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$33K
  • Davol Inc.$136
  • Sanofi$57
  • Harmony Biosciences LLC$31
  • Actelion Pharmaceuticals US, Inc.$27
  • Takeda Pharmaceuticals U.S.A., Inc.$25
  • plus $35 from 2 others

What the payments were for

  • Consulting fees$1,80085%
  • Food & beverage$31115%

General payments by program year

19
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$33,052 in reported general payments places this provider in the 80th percentile of 703 pulmonary disease providers in Pennsylvania.

See all pulmonary disease providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$39,878
Medicare patients
139
Services billed
440

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pulmonary disease in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →